Tissue Regeneration Therapeutics Inc. (TRT) is a progressive biotechnology company with a focus on the commercial development of their patented Human Umbilical Cord PeriVascular Cell (HUCPVC) platform technology. By providing license opportunities to collaborating partner companies we create cell and regenerative strategies that maximize the utility of publicly sourced tissue – for therapies that address important health care issues of today.
TRT has discovered the world’s richest source of mesenchymal stem cells (MSCs) with potent regenerative, angiogenic, anti-inflammatory and immuno-regulatory properties; and is the first company in the world to have issued and allowed patents in US and Europe for extraction of these unique cells from umbilical cord tissue.
Together, we build very powerful biology.
Company Details
- Employees
- 4
- Founded
- -
- Address
- 790 Bay Street Suite 512, Box 55, Toronto,on M5g 1n8,canada
- Phone
- 1.416.345.0039
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- verypowerfulbiology.com
- HQ
- Toronto, ON
Tissue Regeneration Therapeutics Questions
Tissue Regeneration Therapeutics's helpline number is 1.416.345.0039
Tissue Regeneration Therapeutics's website is verypowerfulbiology.com
Tissue Regeneration Therapeutics's LinkedIn profile is https://ca.linkedin.com/company/tissue-regeneration-therapeutics
Tissue Regeneration Therapeutics has
4 employees.
View email and phone details for 4
employees at Tissue Regeneration Therapeutics.
Tissue Regeneration Therapeutics's industry is
Biotechnology Research
Tissue Regeneration Therapeutics's top competitors are
Ge Healthcare,
Regentx, Llc,
Biotissue,
Omniabio,
Ccrm,
Cytiva,
Bluerock Therapeutics,
Marken,
Cellular Logistics Inc.,
Tissue Regenix Group.
Tissue Regeneration Therapeutics's categories are Biotechnology Research
Tissue Regeneration Therapeutics's founding year is 2004
